81.92USD+1.36%Mkt Cap: 1.86B $P/E: 20.951d ago
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel …
Industry Peers
Drug Manufacturers - Specialty & Generic$65.19BUSDP/E 23.7
$22.46BUSDP/E 19.5
$20.18BUSD
$17.25BUSDP/E 26.4
$15.47BUSDP/E 179.2
$14.18BUSDP/E 29.7
$12.96BUSD
$8.93BUSDP/E 22.7
$7.80BUSD
$6.84BUSDP/E 25.1
$6.69BUSDP/E 442.8
$5.76BUSDP/E 48.8
$3.65BUSDP/E 19.0
$3.55BUSDP/E 11.3
$2.99BUSDP/E 20.9
$2.80BUSD
$2.52BUSDP/E 56.0
$2.35BUSDP/E 16.3
$2.40BUSDP/E 12.9
$2.31BUSD
$1.92BUSDP/E 19.4
$1.89BUSD
$1.71BUSD
$1.89BUSD
$1.67BUSD
$1.48BUSDP/E 17.5
$1.50BUSDP/E 124.1
$1.40BUSDP/E 14.8
$1.12BUSDP/E 35.4
$1.18BUSDP/E 17.6
$1.23BUSD
$1.06BUSDP/E Infinity
$1.02BUSD
$1.01BUSDP/E 196.9
$985.07MUSD
$918.60MUSDP/E 14.7
$873.22MUSDP/E 38.1
$875.69MUSDP/E 12.0
$819.46MUSDP/E Infinity
$668.29MUSD
$692.84MUSDP/E 161.5
$637.05MUSDP/E 6.2
$505.77MUSDP/E 14.3
$494.34MUSD
$447.41MUSD
$427.80MUSD
$396.78MUSD
$375.56MUSD
$370.76MUSD
$355.90MUSD
$343.56MUSD
$357.30MUSD
$320.48MUSDP/E 43.7
$294.94MUSDP/E 15.2
$303.08MUSDP/E 9.7
$273.62MUSDP/E 49.1
$285.23MUSD
$250.29MUSDP/E 47.6
$255.34MUSDP/E 12.7
$236.39MUSDP/E 53.0
$206.95MUSDP/E 10.3
$210.49MUSD
$195.77MUSD
$185.67MUSD
$182.70MUSDP/E 8.8
$164.20MUSD
$143.26MUSDP/E 18.3
$146.07MUSD
$133.59MUSD
$126.10MUSD
$119.66MUSDP/E 18.6
$114.77MUSD
$83.73MUSDP/E 12.0
$94.75MUSD
$72.66MUSD
$67.25MUSD
$70.06MUSD
$62.42MUSDP/E 52.6
$63.44MUSDP/E 21.8
$60.48MUSD
$63.41MUSD
$53.86MUSD
$50.62MUSD
$49.37MUSD
$48.31MUSD
$42.20MUSD
$41.16MUSD
$33.86MUSDP/E Infinity
$31.75MUSD
$27.85MUSD
$26.87MUSD
$23.61MUSDP/E 204.0
$23.18MUSD
$22.62MUSD
$22.15MUSD
$18.56MUSD
$17.65MUSD
$14.93MUSD
$13.84MUSDP/E 16.8
$14.21MUSD
$11.64MUSD
$11.91MUSD
$9.88MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.05MUSDP/E 3.7
$6.17MUSD
$6.48MUSDP/E 0.3
$5.84MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$2.01MUSD
$1.93MUSD
$2.08MUSDP/E 35.5
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap1.86B $
Enterprise Value2.04B $
Revenue (TTM)923.71M $
Gross Profit542.06M $
Net Income (TTM)78.34M $
Revenue/Share45.33 USD
Last Price81.92 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees970
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS00182C1036
Valuation
P/E (Trailing)20.95
P/E (Forward)7.59
PEG—
EV/EBITDA10.34
EV/Revenue2.21
P/S2.02
P/B3.11
EPS (TTM)3.91
EPS (Forward)10.80
52W Range
62.6152% of range99.50
52W High99.50 USD
52W Low62.61 USD
Profitability
Gross Margin61.36%
Oper. Margin16.30%
EBITDA Margin21.37%
Profit Margin8.87%
ROE14.49%
ROA5.44%
Growth
Revenue Growth20.50%
Earnings Growth86.10%
Cash Flow & Leverage
Operating CF185.22M $
CapEx (TTM)34.32M $
FCF Margin15.18%
FCF Yield7.53%
Net Debt304.15M $
Net Debt/EBITDA1.54
Balance Sheet
Debt/Equity1.14
Current Ratio3.12
Quick Ratio2.43
Book Value/Sh26.34 USD
Cash/Share15.38 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateJul 18, 2013
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)112.71 USD
Upside (mean)+37.6%
Target Range100.00 USD – 124.00 USD
$100.00+37.6% to mean$124.00
# Analysts7
Ownership
Shares Out.22.73M
Float19.42M
Insiders5.54%
Institutions110.36%
Short Interest
Short Ratio10.4d
Short % Float18.48%
Short % Out.15.14%
Shares Short3.44M
Short (prev mo.)3.32M
Technical
SMA 5081.52 (+0.5%)
SMA 20081.93 (-0.0%)
Beta0.43
S&P 52W Chg20.25%
Avg Vol (30d)300.64K
Avg Vol (10d)309.47K
Technical Indicators
RSI (14)49.2
MACD0.1943
MACD Signal0.6124
MACD Hist.-0.4181
BB Upper86.43 USD
BB Middle82.71 USD
BB Lower78.99 USD
BB Width9.00%
ATR (14)2.644 USD
Vol Ratio (20d)0.73x